Healthcare & Life Sciences: Drug Pricing Digest - July 2021

Latham & Watkins LLP
Contact

Drug Pricing Initiatives: Debate continues regarding the drug pricing measures pending in Congress. On June 22, 2021, Senate Finance Committee Chair Ron Wyden released legislative principles that, among other things, would extend to commercial insurers the same drug prices that Medicare negotiates. At the same time, Democratic lawmakers are reportedly discussing which health policies to include in upcoming legislation as part of a reconciliation package. For example, House Energy and Commerce Health Subcommittee Chair Anna Eshoo reportedly wants to include policies that both close the Medicaid coverage gap and extend Medicare coverage to additional benefits.

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.